Cardiovascular factors predicting poor outcome in COVID-19 patients.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

15 citing papers in PubMed.

1. "Heart failure in COVID-19 patients: Critical care experience": A letter to the editor.World journal of virology · 2022
   Article
2. Comparison Epidemiology between Tuberculosis and COVID-19 in East Java Province, Indonesia: An Analysis of Regional Surveillance Data in 2020.Tropical medicine and infectious disease · 2022
   Article
3. Infective endocarditis and COVID -19 coinfection: An updated review.Acta bio-medica : Atenei Parmensis · 2022
   Review
4. Heart failure in COVID-19 patients: Critical care experience.World journal of virology · 2022
   Review
5. A review of the presentation and outcome of left ventricular thrombus in coronavirus disease 2019 infection.Journal of clinical and translational research · 2021
   Review
6. Cardiology and COVID-19: do we have sufficient information?Future cardiology · 2021
   Review
7. A review on how to do hematology consults during COVID-19 pandemic.Blood reviews · 2021
   Review
8. SARS-CoV-2 Mediated Hyperferritinemia and Cardiac Arrest: Preliminary Insights.Drug discovery today · 2021
   Review
9. Coagulopathy, endothelial dysfunction, thrombotic microangiopathy and complement activation: potential role of complement system inhibition in COVID-19.Journal of thrombosis and thrombolysis · 2021
   Review
10. Optimal cut-off value of elevated cardiac troponin concentrations for myocardial injury predicts clinical outcomes in adult patients with COVID-19: a dose-response analysis protocol for systematic review.BMJ open · 2021
    Article
11. Tuberculosis and COVID-19 Co-infection: An Updated Review.Acta bio-medica : Atenei Parmensis · 2020
    Review
12. Challenges of Maintaining Optimal Nutrition Status in COVID-19 Patients in Intensive Care Settings.JPEN. Journal of parenteral and enteral nutrition · 2020
    Review
13. Letter to the Editor Regarding "Acute Stroke Management During the Coronavirus Disease 2019 (COVID-19) Pandemic: From Trough of Disillusionment to Slope of Enlightenment".World neurosurgery · 2020
    Article
14. Impact on mental health by "Living in Isolation and Quarantine" during COVID-19 pandemic.Journal of family medicine and primary care · 2020
    Article
15. COVID-19 Pandemic and Children: A Review.The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG · 2020
    Review

Corrections and comments

• Comment on
  Pathophysiological characteristics and therapeutic approaches for pulmonary injury and cardiovascular complications of coronavirus disease 2019.

Authors and funding

4 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as